Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Head and Neck Neoplasms 3Colonic Neoplasms 3Chronic Pain 3Cancer Pain 3Supratentorial Neoplasms 2Pain, Postoperative 2Pain 2Neoplastic Cells, Circulating 2Neoplasms 2Colorectal Neoplasms 2Agnosia 2Substance Withdrawal Syndrome 1Stomach Neoplasms 1Rectal Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Nalbuphine Allergy 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Breakthrough Pain 1Brain Neoplasms 1Age Problem 1Abdominal Cancer 1

Interventions

Vincristine 3Methotrexate 3Mercaptopurine 3Etoposide 3Daunorubicin 3Cytarabine 3Cyclophosphamide 3Asparaginase 3Vindesine 2Thioguanine 2Teniposide 2Stem Cell Transplantation 2Prednisolone 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Dexamethasone 2pegaspargase 1fludarabine 1etoposide phosphate 1blinatumomab 1aldesleukin 1Rituximab 1Prednisone 1Pirinitramide 1Morphine 1Interleukin-2 1Idarubicin 1Histamine 1Cladribine 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Neoplasm, Residual × Morphine × Clear all
NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡